Investor Alert

London Markets Open in:

Company Close Updates

Sept. 14, 2021, 4:55 p.m. EDT

Gilead Sciences Inc. stock outperforms competitors on strong trading day

MarketWatch Automation

Shares of Gilead Sciences Inc. (NAS:GILD) inched 0.01% higher to $70.45 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index (S&P:SPX) falling 0.57% to 4,443.05 and Dow Jones Industrial Average (DOW:DJIA) falling 0.84% to 34,577.57. The stock's fall snapped a two-day winning streak. Gilead Sciences Inc. closed $2.89 short of its 52-week high ($73.34), which the company reached on August 18th.

The stock outperformed some of its competitors Tuesday, as Johnson & Johnson (NYS:JNJ) fell 0.60% to $164.80, Merck & Co. Inc. (NYS:MRK) fell 0.58% to $72.11, and AbbVie Inc. (NYS:ABBV) fell 0.93% to $106.48. Trading volume (5.5 M) remained 495,234 below its 50-day average volume of 6.0 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.